BORDI, Cesare
 Distribuzione geografica
Continente #
NA - Nord America 1.873
EU - Europa 1.430
AS - Asia 683
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 1
OC - Oceania 1
Totale 3.994
Nazione #
US - Stati Uniti d'America 1.826
CN - Cina 547
IE - Irlanda 337
UA - Ucraina 285
SE - Svezia 274
FI - Finlandia 246
DE - Germania 148
TR - Turchia 70
IT - Italia 54
GB - Regno Unito 53
IN - India 52
CA - Canada 47
BE - Belgio 19
SG - Singapore 7
EU - Europa 6
IR - Iran 5
FR - Francia 4
RU - Federazione Russa 3
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
NL - Olanda 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 3.994
Città #
Chandler 375
Dublin 337
Jacksonville 315
Beijing 140
Dearborn 138
Ashburn 120
Ann Arbor 116
Nanjing 83
San Mateo 69
Princeton 68
Izmir 67
Pune 48
Wilmington 45
Toronto 43
Woodbridge 35
Kunming 33
Shanghai 31
Nanchang 30
Boardman 27
Jinan 25
Shenyang 24
Helsinki 23
New York 22
Parma 21
Brussels 19
Hebei 19
Hefei 18
Tianjin 18
Jiaxing 15
Changsha 14
Hangzhou 13
Guangzhou 12
Auburn Hills 11
Bremen 10
Des Moines 9
Haikou 9
Chengdu 7
Lanzhou 6
Los Angeles 6
Norwalk 6
Wenzhou 6
Zhengzhou 6
Ningbo 5
Seattle 5
Borås 4
Fremont 4
Fuzhou 4
Houston 4
Rio Saliceto 4
Taizhou 4
Andover 3
Baotou 3
Falls Church 3
Kocaeli 3
Ottawa 3
Rockville 3
Düsseldorf 2
Kashan 2
Leawood 2
Luzzi 2
Sacramento 2
Taiyuan 2
Xian 2
Augusta 1
Bangalore 1
Budapest 1
Cairo 1
Changchun 1
Chaoyang 1
Chiayi County 1
Chicago 1
Chongqing 1
Copenhagen 1
Cormeilles-en-Parisis 1
Gatchina 1
Grafing 1
Harbin 1
Henderson 1
Huzhou 1
Las Vegas 1
London 1
Madrid 1
Medolla 1
Melbourne 1
Montréal 1
Mumbai 1
North Charleston 1
Omsk 1
Orange 1
Prague 1
Quzhou 1
Ramenskoye 1
Singapore 1
Stockholm 1
Stuttgart 1
Timisoara 1
Zanjan 1
Zurich 1
Totale 2.540
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 103
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 92
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 89
Classification of gastric endocrine cells at the light and electron microscopical levels 87
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 82
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 78
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 76
Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding 75
The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. 75
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 74
È L’ANGIOGENESI UN FATTORE PROGNOSTICO NEGLI ADENOCARCINOMI DEL COLON-RETTO IN STADIO B DI DUKES? 74
Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome 73
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 73
Endocrine tumors of the gastrointestinal system 72
Poorly differentiated endocrine carcinoma 71
Classification of neuroendocrine tumours 71
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. 71
Pleomorph poorly differentiated endocrine carcinoma of the rectum 68
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy 66
Biclonality of gastric lymphomas 66
Aetiology, molecular pathogenesis and genetics 66
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 66
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 65
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 65
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas 65
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 65
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 64
Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case 62
Criteria for malignancy in gastrointestinal endocrine tumors 62
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 62
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I 61
Multiple endocrine neoplasia type 1 60
Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. 60
Heterotopic mesenteric ossification (Intraabdominal myositis ossificans): Report of five cases 59
AMPULLARY ADENOCARCINOMA IN VON RECKLINGHAUSEN’S DISEASE. CASE REPORT AND LITERATURE REVIEW. 59
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 58
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 58
Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture 58
Non-functioning tumours and microadenomas 57
Gastric neuroendocrine neoplasms: tumor clonality and malignancy associated large X-chromosomal deletions 57
Pancreatic endocrine tumours: Introduction 56
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 55
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases 53
Different patterns of 11q allelic losses in digestive endocrine tumors 52
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas 52
Multiple endocrine neoplasia (MEN)-associated tumours 52
Mucosal colonization of gastric endocrine tumors mimicking mixed neoplasms 50
Gastrinomas 49
Mixed exocrine-endocrine carcinomas 49
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection 48
Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis 47
Highlights on biology of endocrine tumours of the gut and pancreas 47
Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: Associations with clinicopathological and molecular features 46
Prognostic factors in gastrointestinal endocrine tumors 45
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 45
Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up 44
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 44
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma 43
PTU-064 Identification of Syne 1 and Foxe 1 Hypermethylation to improve diagnosis and amangement of colorectal neoplasia in Inflammatory Bowel disease 43
Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool 42
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. 42
Hypergastrinemia and gastric enterochromaffin-like cells 40
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization 38
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 34
The normal endocrine cell of the gut. Changing concepts and new evidences 31
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p 30
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets 29
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids 29
Totale 4.000
Categoria #
all - tutte 11.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019111 0 0 0 0 0 0 0 0 0 6 88 17
2019/2020973 128 163 70 26 81 98 114 20 90 97 14 72
2020/2021465 4 65 64 7 63 4 62 4 104 14 69 5
2021/2022367 11 2 2 26 13 7 48 64 17 31 46 100
2022/20231.269 147 135 55 107 114 141 16 73 428 4 37 12
2023/2024329 29 41 5 2 37 153 22 29 5 6 0 0
Totale 4.000